TuHURA Biosciences Inc.

HURA | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.15

-$0.03 (-1.38%)

Sep 22, 2026, 11:07 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $138.83M

Enterprise Value $138.24M

Beta -0.01

Average Volume 458.36K

Shares Outstanding (Diluted) 63.96M

Shares Change YoY 43.56%

Institutional Ownership 15.84%

Exchange NASDAQ

ISIN US8989201038

Price Performance

Price Change 1M 6.3%

Price Change 3M -17.4%

Price Change 6M 9.6%

Price Change YTD 190.9%

Price Change 1Y -14.5%

Price Change 3Y -50.0%

Price Change 5Y -95.0%

1M CAGR (ann.) 2.4%

1Y CAGR (ann.) -15.5%

5Y CAGR (ann.) -50.2%

All-Time CAGR -41.8%

Valuation

PE Ratio -4.04

Forward PE N/A

PEG Ratio -0.04

Forward PEG -0.34

PS Ratio N/A

Forward PS 6.20

PB Ratio 7.50

P/FCF Ratio -4.64

P/Adj. FCF Ratio -3.90

P/OCF Ratio -4.74

EV/Sales N/A

EV/EBIT -4.68

EV/EBITDA -4.70

EV/FCF -4.62

Earnings Yield -24.8%

FCF Yield -21.5%

Adj. FCF Yield -25.7%

Financial Health

Net Cash $588.95K

Total Debt $407.02K

Cash & Short-Term Investments $995.98K

Total Assets $31.75M

Current Ratio 0.18

Quick Ratio 0.18

Debt / Equity Ratio 0.02

Debt / EBITDA -0.01

Debt / FCF -0.01

OCF / Debt -72.94

Interest Coverage -27.83

Altman Z-Score -4.03

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -19.2%

Returns

Return on Assets -96.5%

Return on Equity -154.3%

Return on Invested Capital -137.4%

Return on Capital Employed -138.7%

Return on Tangible Assets -145.8%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 142.5%

EPS CAGR 5Y 81.5%

EPS CAGR 10Y 39.0%

FCF CAGR 3Y -54.7%

FCF CAGR 5Y -14.8%

FCF CAGR 10Y -16.3%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 3

EPS Growth Next 3Y 148.8%

Revenue Growth Next 3Y N/A

Earnings Date Nov 12, 2026

EPS Estimate (next Q) -$0.14

EPS Growth Est (next Q) 0.0%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $9

Price Target Upside 312.8%

Cash Flow

Operating Cash Flow $-29.69M

Free Cash Flow $-29.9M

Adj. Free Cash Flow $-35.64M

FCF Per Share -$0.47

OCF Per Share -$0.46

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-23.47K

Operating Income $-31.2M

EBITDA $-29.44M

Net Income $-30.63M

EPS (Diluted) -$0.54

Revenue / Employee N/A

Profit / Employee $-1.39M

Employees 22